Fluconazole susceptibility testing of Cryptococcus neoformans: Comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients

Journal of Clinical Microbiology

Volumn 36, Issue 10, 1998, Pages 2874-2876

  Jessup, C J ^a   Pfaller, M A ^b   Messer, S A ^b   Zhang, J ^b   Tumberland, M ^c   Mbidde, E K ^d   Ghannoum, M A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UGANDA CANCER INSTITUTE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UGANDA;

CRYPTOCOCCUS NEOFORMANS VAR. NEOFORMANS; FILOBASIDIELLA NEOFORMANS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031655737     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.10.2874-2876.1998     Document Type: Article

References (22)

1. Barchiesi, F., R. J. Hollis, S. A. Messer, G. Scalise, M. G. Rinaldi, and M. A. Pfaller. 1995. Electrophoretic karyotype and in vitro susceptibility of Cryptococcus neoformans isolates from AIDS patients. Diagn. Microbiol. Infect. Dis. 23:99-103.
2. Berg, J., C. J. Clancy, and M. H. Nguyen. 1998. The hidden danger of primary fluconazole prophylaxis in patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 26:186-187.
3. Brandt, M. E., M. A. Pfaller, R. A. Hajjeh, E. A. Gravis, J. Rees, E. D. Spitzer, R. W. Pinner, L. W. Mayer, and the Cryptococcal Disease Active Surveillance Group. 1996. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. J. Infect. Dis. 174:812-820.
4. Casadevall, A., E. D. Spitzer, D. Webb, and M. G. Rinaldi. 1993. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob. Agents Chemother. 37:1383-1386.
5. Ghannoum, M. A., A. S. Ibrahim, Y. Fu, M. C. Shafiq, J. E. Edwards, Jr., and R. S. Criddle. 1992. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J. Clin. Microbiol. 30:2881-2886.
6. Kirkpatrick, W. R., R. K. McAtee, S. G. Revankar, A. W. Fothergill, D. I. McCarthy, M. G. Rinaldi, and T. F. Patterson. 1998. Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans. J. Clin. Microbiol. 36:1330-1332.
7. Kwon-Chung, K. J., I. Polacheck, and J. E. Bennett. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15:535-537.
8. Millon, L., A. Manteaux, G. Reboux, C. Drobacheff, M. Monod, T. Barale, and Y. Michel-Briand. 1994. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J. Clin. Microbiol. 32:1115-1118.
9. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcus in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
10. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Nguyen, M. H., and C. Y. Yu. 1998. In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates. Antimicrob. Agents Chemother. 42:471-472.
12. Patterson, T. F. 1997. Cryptococcosis in HIV-infected and non-HIV-infected hosts. Int. J. Infect. Dis. 1(Suppl. 1):S64-S69.
13. Pfaller, M., J. Zhang, S. Messer, M. Tumberland, E. Mbidde, C. Jessup, and M. Ghannoum. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates in Ugandan AIDS patients. Submitted for publication.
14. Pfaller, M. A., J. Zhang, S. A. Messer, M. E. Brandt, R. A. Hajjeh, C. J. Jessup, M. Tumberland, E. K. Mbidde, and M. A. Ghannoum. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Submitted for publication.
15. Powderly, W. G. 1996. Editorial response: management of cryptococcal meningitis - have we answered all the questions? Clin. Infect. Dis. 22:329-330.
16. Redding, S., J. Smith, G. Farinacci, M. G. Rinaldi, A. W. Fothergill, J. Rhine-Chalberg, and M. A. Pfaller. 1994. Development of resistance to fluconazole among isolates of Candida albicans obtained during treatment of oropharyngeal candidiasis in AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
17. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
18. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Clin. Infect. Dis. 24:235-247.
19. Sanati, H., S. A. Messer, M. Pfaller, M. Witt, R. Larsen, A. Espinel-Ingroff, and M. Ghannoum. 1996. Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole. J. Clin. Microbiol. 34:1280-1282.
20. Warren, N. G., and K. C. Hazen. 1995. Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
21. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
22. Witt, M. D., R. J. Lewis, R. A. Larsen, E. N. Milefchik, M. A. E. Leal, R. H. Haubrich, J. A. Richie, J. E. Edwards, Jr., and M. A. Ghannoum. 1996. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin. Infect. Dis. 22:322-328.